Current understanding of the efficacy and safety of alkoxyglycerides and the refined fraction of Ecomer shark liver oil. Publication 1: Analysis of the results of preclinical studies
AUTHORS : Kiseleva T.L.
RELEVANT UNIVERSITIES : FSBI “Research Institute of Nutrition of the Russian Academy of Medical Sciences”, Research Center NO “Professional Association naturotherapists “, Moscow
YEAR : 2014
SUMMARY From an array of bibliographic sources of varying degrees of reliability, we identified and analyzed the results of preclinical studies of alkoxyglycerides (AKG), crude and purified Ecomer shark liver oil – Ecomer® (Natumin Pharma, Sweden). The results of toxicological studies confirm the absence of toxicity and mutagenicity of Ecomer® and its scientifically based composition. Based on the study, the experimental evidence base on the immunomodulatory and antitumor types of action of the standardized product from the liver oil of deep-sea sharks of
the northern seas “Ecomer” can be considered sufficient.
